The new edition of this popular, well-established textbook addresses the expanding role of the pharmacist in treating patients. It covers treatment of common diseases as well as other medical, therapeutic and patient related issues. Written by both pharmacists and clinicians to reflect a team approach, it offers an in-depth analysis of drug therapy in the treatment of disease, relying on input from the pharmacist as a member of the "team" in hospital and community settings. Information is easy to locate in a logical format organized primarily by systems and disorders.
For the past 65 years, The Washington Manual® of Medical Therapeutics, now in its Thirty-Fourth Edition, has been one of the best-selling medical texts in the world. It builds upon that proud tradition--with even more of the current information you need, and delivered in a time-saving, quick-reference style. Its comprehensiveness and ease of access makes it a favorite on-call resource for housestaff and faculty around the world. Continuing the tradition of excellence, each chapter has been updated and reformatted for easier access to the information the reader needs. Inside this edition you’ll find... • New streamlined format that helps you keep pace with the latest advances in the field while removing redundancies and outdated information • New chapter on toxicology prepares you to respond effectively to any poisoning, overdose, or exposure emergency • Decision support algorithms for quick reference See why The Washington Manual® is the most vital on-call resource for house staff and faculty around the world!
This book covers all the pharmacology you need, from basic science pharmacology and pathophysiology, through to clinical pharmacology to therapeutics, in line with the integrated approach of new medical curricula. The first section covers the basic principles, and the rest is organised by body systems. The book ends with sections on toxicity and prescribing practice. Integrates basic science pharmacology, clinical pharmacology and therapeutics Brief review of pathophysiology of major diseases Case histories and multiple choice questions (and answers) Tabular presentation of all common drugs within each class Section on further reading Kinetics chapter simplified with more practical examples Includes more on genetic issues Drug tables made more concise to make information more accessible Fully updated to reflect current clinical practice
A must-have companion for medical students and junior doctors for almost four decades, Lecture Notes: Clinical Pharmacology and Therapeutics provides concise yet thorough coverage of the principles of clinical pharmacology, the major characteristics of therapeutics, and the practical aspects of prescribing drugs to alleviate symptoms and to treat disease. Whether you are preparing for examinations or prescribing to patients, the tenth edition offers readers current and authoritative insight into the essential practical and clinical knowledge. Logically organised chapters allow for rapid location of key information, while examples of commonly encountered scenarios illustrate how and when to use drugs in clinical situations. Throughout the text, practice questions, prescribing guidelines, and self-assessment tests clarify and reinforce the principles that inform appropriate clinical decision-making. Presents an up-to-date review of drug use across all major clinical disciplines Offers a timely overview of clinical drug trials and development Provides new clinical scenarios to relate chapter content to real-life application Contains colour-coded "Key Points" and "Prescribing Points" to highlight important information Includes chapter introductions and summaries, and numerous figures, tables, and colour illustrations Lecture Notes: Clinical Pharmacology and Therapeutics, Tenth Edition, is an essential resource for medical students, junior doctors, and other prescribers looking for an up-to-date reference on pharmacological principles, prescribing, and therapeutics.
THE LATEST THERAPEUTIC TREATMENT OPTIONS IN INTERNAL MEDICINE--AT YOUR FINGERTIPS This peer-reviewed guide highlights important therapeutic treatment options for the most common diseases managed by clinicians practicing internal medicine. SHORT BULLETED CONTENT for ease of use in a clinical setting ORGANIZED BY DISEASE STATE CLINICAL PEARLS to aid in disease management EMBEDDED REFERENCES to facilitate further research DRUG TABLES that include product availability, disease-specific dosing, common adverse reactions and drug/drug interactions SECTIONS INCLUDE: Cardiology, Pulmonary, Gastroenterology, Nephrology, Nutrition, Hematology and Oncology, Infectious Disease, Rheumatology, Psychiatry, Pain, and Transplant HELPFUL APPENDICES INCLUDE: Antidotes, Immunizations, Intrathecal Injections, Intravenous Immunoglobulin, Lab/Drug Interactions and Drug Abuse, Mechanical Ventilation, QT Prolongation, and Steroid Conversion Chart
Ocular Therapeutics Handbook: A Clinical Manual is directed at the needs of optometrists, nurses and primary care physicians and provides succinct, rapid access information for most common ocular problems encountered in a primary care setting. It is divided into three sections: Quick Reference, Ocular Therapeutics and Appendices. The Quick Reference section covers such topics as ocular microbiology, lab tests and procedures, pharmaceutical agents, and side effects of medications. The Ocular Therapeutics section discusses diseases, traumatic injuries, and ocular urgencies and emergencies. The appendices provide a summary of abbreviations, conversion charts, case report sheets and important phone numbers. The chapters have been developed to serve as a snapshot, presenting the clinician with the most relevant information regarding the pathophysiology and etiology of diseases, patient demographics, signs and symptoms, lab tests, and recommended approaches to treatment.
A comprehensive review of contemporary antisense oligonucleotides drugs and therapeutic principles, methods, applications, and research Oligonucleotide-based drugs, in particular antisense oligonucleotides, are part of a growing number of pharmaceutical and biotech programs progressing to treat a wide range of indications including cancer, cardiovascular, neurodegenerative, neuromuscular, and respiratory diseases, as well as other severe and rare diseases. Reviewing fundamentals and offering guidelines for drug discovery and development, this book is a practical guide covering all key aspects of this increasingly popular area of pharmacology and biotech and pharma research, from the basic science behind antisense oligonucleotides chemistry, toxicology, manufacturing, to safety assessments, the design of therapeutic protocols, to clinical experience. Antisense oligonucleotides are single strands of DNA or RNA that are complementary to a chosen sequence. While the idea of antisense oligonucleotides to target single genes dates back to the 1970's, most advances have taken place in recent years. The increasing number of antisense oligonucleotide programs in clinical development is a testament to the progress and understanding of pharmacologic, pharmacokinetic, and toxicologic properties as well as improvement in the delivery of oligonucleotides. This valuable book reviews the fundamentals of oligonucleotides, with a focus on antisense oligonucleotide drugs, and reports on the latest research underway worldwide. • Helps readers understand antisense molecules and their targets, biochemistry, and toxicity mechanisms, roles in disease, and applications for safety and therapeutics • Examines the principles, practices, and tools for scientists in both pre-clinical and clinical settings and how to apply them to antisense oligonucleotides • Provides guidelines for scientists in drug design and discovery to help improve efficiency, assessment, and the success of drug candidates • Includes interdisciplinary perspectives, from academia, industry, regulatory and from the fields of pharmacology, toxicology, biology, and medicinal chemistry Oligonucleotide-Based Drugs and Therapeutics belongs on the reference shelves of chemists, pharmaceutical scientists, chemical biologists, toxicologists and other scientists working in the pharmaceutical and biotechnology industries. It will also be a valuable resource for regulatory specialists and safety assessment professionals and an important reference for academic researchers and post-graduates interested in therapeutics, antisense therapy, and oligonucleotides.
